Oleg Nodelman’s EcoR1 Capital Betting On Transcept Pharmaceuticals Inc (TSPT)
Oleg Nodelman's EcoR1 Capital disclosed a new $2.3 Transcept Pharmaceuticals Inc (NASDAQ:TSPT) on Friday.
Posts Tagged ‘NASDAQ:TSPT’
Roumell Cuts Exposure to Transcept Pharmaceuticals (TSPT) and Ups Stake in DSP Group (DSPG)
Jim Roumell’s Roumell Asset Management, filed yesterday, two forms disclosing its current positions in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) and DSP Group, Inc.
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Roumell Asset Management Salutes Actions Taken at Transcept Pharmaceuticals Inc (TSPT)
Jim Roumell's fund Roumell Asset Management, has disclosed, in a newly amended filing, that it has sent a letter to the board of directors of Transcept Pharmaceuticals Inc (...
Roumell Asset Management Further Limits Exposure to Transcept Pharmaceuticals Inc (TSPT)
Roumell Asset Management, run by Jim Roumell, is reducing its exposure to Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
SC Fundamental Value Fund Send Letter to Transcept Pharmaceuticals Inc (TSPT); Request Special Shareholder Meeting
SC Fundamental Value Fund, L.P. is unhappy with the management of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
Roumell Asset Management Nominates Candidates for Transcept Pharmaceuticals Inc (TSPT)’s Board
Roumell Asset Management, led by Jim Roumell, disclosed, in a new filing with the Securities and Exchange Commission, a letter sent to the board of Transcept Pharmaceuticals...
Roumell Asset Management Continues Selling Transcept Pharmaceuticals
Roumell Asset Management, led by Jim Roumell, continues selling shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
Roumell Again Reduces Position in Transcept Pharmaceuticals
Jim Roumell's hedge fund, Roumell Asset Management, in a new form 4 filed with the SEC, reported selling some shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
Roumell Sells a Small Amount of Transcept Pharmaceuticals
Jim Roumell's Roumell Asset Management reported reducing its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) to some 2.3 million shares.
SC Fundamental Value Calls on Transcept Pharmaceuticals to Remove Four Board Members
SC Fundamental Value, Transcept: Transcept Pharmaceuticals Inc (NASDAQ:TSPT) was given support in the equity portfolio of SC Fundamental Value, a filing with the SEC shows.
Hedge Fund Filings: After-Market 13D Watch
2) James Roumell and Roumell Asset Management, whom we track, owns shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT).
Transcept Pharmaceuticals News: Roumell Asset Management’s Thoughts on Retrophin
Transcept Pharmaceuticals news: Transcept Pharmaceuticals Inc (NASDAQ:TSPT) is a small-cap stock that recently was cut slightly in the equity portfolio of Roumell Asset Management...
The Procter & Gamble Company (PG): Can’t Sleep? Don’t Worry, You’re Not Alone
Blame it on a "case of the Mondays" or perhaps a rough night out on the town, but for many of us getting a good night's rest isn't nearly as simple as it sounds.
